Why the new GLP-1 pill is such a big deal
The semaglutide revolution took its next leap forward on Wednesday: The Food and Drug Administration has approved Eli Lilly’s GLP-1 oral pill for sale in the United States. The approval for the drug, which will be sold under the brand name Foundayo, marks an important technological inflection point for this class of drugs that is […]
📰 Original Source
Read full article at Vox →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.